Highlands Oncology Group Sponsors 2nd Annual NWA Metsquerade
Highlands Oncology Group Will Sponsor Event Benefiting Late-Stage Breast Cancer Research
Rogers, Arkansas, April 5, 2017 (Newswire.com) - Highlands Oncology Group, Northwest Arkansas’ leading cancer treatment provider, is sponsoring the second annual Northwest Arkansas METSquerade, benefiting metastatic breast cancer research. The masquerade event will be from 6 p.m. to 11 p.m. on April 8th at the John Q Hammons Center in Rogers. Funds raised will benefit METAvivor, an organization which dedicates all proceeds toward metastatic breast cancer research.
METAvivor is the only organization in the US that exclusively funds metastatic breast cancer research through a scientific peer-review process, according to their website. The group awards grants to individuals who are actively engaged in areas of metastatic breast cancer research and whose proposals show distinct promise in making a difference for the stage four breast cancer community. The mission of the group is to transition metastatic breast cancer from a terminal diagnosis to a chronic, manageable disease with a decent quality of life.
Metastatic breast cancer (also called stage four or advanced breast cancer) is not a specific type of breast cancer, but rather the most advanced stage of breast cancer, according to the Susan G. Komen organization. Metastatic breast cancer is breast cancer that has spread beyond the breast to other organs in the body.
For women in the U.S., breast cancer death rates are higher than those for any other cancer, besides lung cancer, according to breastcancer.org, a non-profit organization dedicated to breast cancer awareness.
As such, Highlands Oncology Group continually hosts and participates in clinical trials and is actively involved in research on treatment options for breast cancer, and many other cancers.
Aside from skin cancer, breast cancer is the most common cancer among American women, according to the American Cancer Society (ACS). In 2017, about 252,710 new cases of invasive breast cancer will be diagnosed and about 40,610 women will die from breast cancer in the United States, according to the ACS.
As the leading cancer treatment and research facility in Northwest Arkansas, Highlands Oncology Group is dedicated to the advancement of cancer treatment and to providing patients with the best possible care and results.
Highlands Oncology Group is honored to sponsor this important event. For more information, please visit: www.nwamets.org.
Highlands Oncology Group is a state-of-the-art facility, with a world-class team of specialists, that is committed to providing premier cancer treatment and to enhancing the quality of life of patients and their loved ones. Highlands Oncology group provides this in a friendly, comfortable environment conveniently located in Northwest Arkansas. Highlands offers the latest technology of diagnostic imaging and radiation therapies, on-site labs, a pharmacy and an infusion center. They also offer access to clinical trials, multidisciplinary clinics and support groups. Highlands Oncology Group is helping patients win the battle against cancer, every day!
For more information, visit: www.HighlandsOncologyGroup.com.
Source: Highlands Oncology Group